Total Payments
$11,000
2024 Payments
$3,354
Companies
57
Transactions
572
Medicare Patients
3,322
Medicare Billing
$450,083
Payment Breakdown by Category
Food & Beverage$10,534 (95.8%)
Education$466.25 (4.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,534 | 566 | 95.8% |
| Education | $466.25 | 6 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $897.79 | 43 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $808.77 | 77 | $0 (2024) |
| ABBVIE INC. | $716.87 | 50 | $0 (2024) |
| UCB, Inc. | $700.77 | 43 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $631.39 | 19 | $0 (2024) |
| Lilly USA, LLC | $580.30 | 33 | $0 (2024) |
| Biogen, Inc. | $447.08 | 16 | $0 (2024) |
| Amgen Inc. | $436.39 | 16 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $404.27 | 7 | $0 (2023) |
| Allergan, Inc. | $346.46 | 16 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,354 | 183 | ABBVIE INC. ($498.03) |
| 2023 | $1,948 | 86 | Supernus Pharmaceuticals, Inc. ($300.19) |
| 2022 | $688.80 | 24 | Biogen, Inc. ($118.86) |
| 2021 | $906.08 | 63 | Teva Pharmaceuticals USA, Inc. ($142.67) |
| 2020 | $828.30 | 45 | Allergan, Inc. ($85.81) |
| 2019 | $1,595 | 95 | Novartis Pharmaceuticals Corporation ($279.29) |
| 2018 | $1,119 | 54 | Teva Pharmaceuticals USA, Inc. ($264.55) |
| 2017 | $560.90 | 22 | Allergan Inc. ($131.28) |
All Payment Transactions
572 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: EPILEPSY | ||||||
| 12/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $6.62 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | Cash or cash equivalent | $109.14 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Immunology and Neurology | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: Musculoskeletal | ||||||
| 11/21/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $8.68 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $2.48 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: EPILEPSY | ||||||
| 11/14/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $39.83 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $1.00 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.51 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,073 | 1,359 | $1.1M | $121,188 |
| 2022 | 10 | 391 | 516 | $147,088 | $39,344 |
| 2021 | 13 | 877 | 6,684 | $514,089 | $127,975 |
| 2020 | 14 | 981 | 10,497 | $615,180 | $161,576 |
Total Patients
3,322
Total Services
19,056
Medicare Billing
$450,083
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 89 | 168 | $79,128 | $15,874 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 143 | $79,365 | $13,549 | 17.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 120 | 126 | $78,624 | $13,091 | 16.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 225 | 254 | $378,672 | $11,107 | 2.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 62 | 119 | $59,212 | $9,694 | 16.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 30 | 30 | $47,040 | $9,638 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $52,021 | $8,768 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 105 | $40,110 | $7,088 | 17.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 48 | $42,864 | $6,567 | 15.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 102 | $33,558 | $6,383 | 19.0% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 25 | 34 | $32,504 | $5,500 | 16.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 32 | 32 | $37,504 | $5,226 | 13.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $16,368 | $2,862 | 17.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 16 | 16 | $15,728 | $2,162 | 13.7% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 31 | 36 | $63,252 | $1,589 | 2.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 29 | $5,162 | $1,156 | 22.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 14 | 14 | $6,482 | $933.94 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 187 | $37,587 | $14,451 | 38.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 37 | $14,319 | $5,700 | 39.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 47 | 85 | $11,730 | $4,706 | 40.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 67 | 71 | $47,996 | $3,058 | 6.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 36 | $7,128 | $2,929 | 41.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 18 | 36 | $6,120 | $2,558 | 41.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,573 | $2,346 | 35.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 12 | 12 | $5,184 | $2,046 | 39.5% |
About Dr. Todd Elmore, MD
Dr. Todd Elmore, MD is a Neurology healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104854439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Elmore, MD has received a total of $11,000 in payments from pharmaceutical and medical device companies, with $3,354 received in 2024. These payments were reported across 572 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($10,534).
As a Medicare-enrolled provider, Elmore has provided services to 3,322 Medicare beneficiaries, totaling 19,056 services with total Medicare billing of $450,083. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Springfield, IL
- Active Since 06/28/2006
- Last Updated 02/06/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1104854439
Products in Payments
- Briviact (Drug) $455.83
- UBRELVY (Drug) $447.95
- EMGALITY (Drug) $442.61
- Aimovig (Biological) $436.39
- KESIMPTA (Drug) $427.38
- TYSABRI (Biological) $393.06
- APTIOM (Drug) $336.07
- OCREVUS (Biological) $297.92
- ZEPOSIA (Drug) $262.29
- INGREZZA (Drug) $249.60
- AJOVY (Drug) $235.57
- BOTOX (Biological) $230.95
- AJOVY (Biological) $214.81
- MAYZENT (Drug) $197.47
- NURTEC ODT (Drug) $196.72
- VYEPTI (Biological) $185.99
- AMPLATZER Occluders (Device) $183.94
- QULIPTA (Drug) $179.42
- ACTHAR (Biological) $171.81
- WATCHMAN (Device) $156.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Springfield
David Clark, Do, DO
Neurology — Payments: $1.1M
Neurology $1.1M
Raymond Englander, Md, MD
Neurology — Payments: $167,481
Neurology $167,481
Dr. Jenifer Zhai, Md, MD
Neurology — Payments: $121,314
Neurology $121,314
Cecile Becker, M.d, M.D
Neurology — Payments: $78,042
Neurology $78,042
Jennifer Lynch, Md, MD
Neurology — Payments: $73,454
Neurology $73,454
Jayant Acharya, Md, MD
Neurology — Payments: $56,046
Neurology $56,046